Earnings

QIAGEN Reports Preliminary Q3 Net Sales Of $548M; Preliminary Q3 Adj EPS $0.65; Co. Suspends FY 2026 Outlook While Transaction With EQT Private Equity Is Pending

Oct 21, 2026 · 05:50 PM ET· updated 1h ago

QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA))) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates (CER). Adjusted diluted

Why It Matters

QIAGEN made $548 million in sales this quarter and earned $0.65 per share. The company paused its future plans because it is waiting for a big ownership change to finish.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

QGEN50.29

+1.39 (+2.84%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.